GNW

GNW
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.873B ▲ | $-35M ▲ | $116M ▲ | 6.193% ▲ | $0.29 ▲ | $191M ▲ |
| Q2-2025 | $1.727B ▼ | $-43M ▼ | $51M ▼ | 2.953% ▼ | $0.12 ▼ | $151M ▼ |
| Q1-2025 | $1.778B ▲ | $18M ▲ | $54M ▲ | 3.037% ▲ | $0.13 ▲ | $152M ▲ |
| Q4-2024 | $1.722B ▼ | $-33M ▼ | $-1M ▼ | -0.058% ▼ | $-0.002 ▼ | $82M ▼ |
| Q3-2024 | $1.844B | $-8M | $85M | 4.61% | $0.2 | $189M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $48.146B ▲ | $88.486B ▲ | $78.665B ▲ | $8.812B ▲ |
| Q2-2025 | $47.469B ▲ | $87.336B ▲ | $77.557B ▼ | $8.788B ▲ |
| Q1-2025 | $7.695B ▼ | $87.256B ▲ | $77.575B ▲ | $8.71B ▲ |
| Q4-2024 | $7.72B ▼ | $86.871B ▼ | $77.44B ▼ | $8.494B ▲ |
| Q3-2024 | $7.747B | $90.76B | $81.505B | $8.311B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $155M ▲ | $87M ▲ | $308M ▲ | $-156M ▲ | $239M ▲ | $87M ▲ |
| Q2-2025 | $90M ▲ | $6M ▼ | $174M ▲ | $-274M ▼ | $-94M ▲ | $6M ▼ |
| Q1-2025 | $54M ▲ | $34M ▲ | $-14M ▼ | $-177M ▲ | $-157M ▼ | $34M ▲ |
| Q4-2024 | $35M ▼ | $27M ▼ | $220M ▼ | $-255M ▲ | $-9M ▼ | $27M ▼ |
| Q3-2024 | $121M | $161M | $240M | $-276M | $125M | $161M |
Revenue by Products
| Product | Q2-2024 | Q3-2024 | Q4-2024 | Q3-2025 |
|---|---|---|---|---|
Life and Annuities Segment | $450.00M ▲ | $430.00M ▼ | $0 ▼ | $410.00M ▲ |
Corporate and Other | $10.00M ▲ | $10.00M ▲ | $0 ▼ | $0 ▲ |
Long Term Care Insurance | $1.01Bn ▲ | $1.14Bn ▲ | $0 ▼ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Genworth today is a transitional story: a legacy insurance group working through the long shadow of its older long‑term care policies while leaning on a solid mortgage insurance business and investing in a technology‑enabled senior‑care platform. Financially, it remains profitable with a more disciplined balance sheet, but with earnings and cash flow that can swing from year to year. Strategically, its deep data, experience, and regulatory know‑how in long‑term care are valuable assets, yet also sources of risk because of the long‑dated promises made to policyholders. The key opportunities lie in successfully modernizing long‑term care offerings, growing CareScout into a recognized platform for aging‑related services, and maintaining Enact’s strength in mortgage insurance. The main uncertainties are execution risk in this pivot, ongoing management of legacy liabilities, and exposure to housing and interest‑rate cycles. How well Genworth manages these trade‑offs will likely define its long‑term trajectory.
NEWS
November 5, 2025 · 4:15 PM UTC
Genworth Financial Announces Third Quarter 2025 Results
Read more
October 31, 2025 · 4:06 PM UTC
CareScout Completes Acquisition of Seniorly
Read more
October 22, 2025 · 8:50 AM UTC
Genworth Issues Statement on UK Court Approval of Santander Appeal Request
Read more
October 15, 2025 · 5:30 PM UTC
CareScout Announces Plan to Acquire Seniorly
Read more
October 9, 2025 · 4:15 PM UTC
Genworth Financial Schedules Earnings Conference Call for November 6
Read more
About Genworth Financial, Inc.
https://www.genworth.comGenworth Financial, Inc. provides insurance products in the United States and internationally. The company operates in three segments: Enact, U.S. Life Insurance, and Runoff. The Enact segment offers mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; and pool mortgage insurance products. The U.S.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.873B ▲ | $-35M ▲ | $116M ▲ | 6.193% ▲ | $0.29 ▲ | $191M ▲ |
| Q2-2025 | $1.727B ▼ | $-43M ▼ | $51M ▼ | 2.953% ▼ | $0.12 ▼ | $151M ▼ |
| Q1-2025 | $1.778B ▲ | $18M ▲ | $54M ▲ | 3.037% ▲ | $0.13 ▲ | $152M ▲ |
| Q4-2024 | $1.722B ▼ | $-33M ▼ | $-1M ▼ | -0.058% ▼ | $-0.002 ▼ | $82M ▼ |
| Q3-2024 | $1.844B | $-8M | $85M | 4.61% | $0.2 | $189M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $48.146B ▲ | $88.486B ▲ | $78.665B ▲ | $8.812B ▲ |
| Q2-2025 | $47.469B ▲ | $87.336B ▲ | $77.557B ▼ | $8.788B ▲ |
| Q1-2025 | $7.695B ▼ | $87.256B ▲ | $77.575B ▲ | $8.71B ▲ |
| Q4-2024 | $7.72B ▼ | $86.871B ▼ | $77.44B ▼ | $8.494B ▲ |
| Q3-2024 | $7.747B | $90.76B | $81.505B | $8.311B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $155M ▲ | $87M ▲ | $308M ▲ | $-156M ▲ | $239M ▲ | $87M ▲ |
| Q2-2025 | $90M ▲ | $6M ▼ | $174M ▲ | $-274M ▼ | $-94M ▲ | $6M ▼ |
| Q1-2025 | $54M ▲ | $34M ▲ | $-14M ▼ | $-177M ▲ | $-157M ▼ | $34M ▲ |
| Q4-2024 | $35M ▼ | $27M ▼ | $220M ▼ | $-255M ▲ | $-9M ▼ | $27M ▼ |
| Q3-2024 | $121M | $161M | $240M | $-276M | $125M | $161M |
Revenue by Products
| Product | Q2-2024 | Q3-2024 | Q4-2024 | Q3-2025 |
|---|---|---|---|---|
Life and Annuities Segment | $450.00M ▲ | $430.00M ▼ | $0 ▼ | $410.00M ▲ |
Corporate and Other | $10.00M ▲ | $10.00M ▲ | $0 ▼ | $0 ▲ |
Long Term Care Insurance | $1.01Bn ▲ | $1.14Bn ▲ | $0 ▼ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Genworth today is a transitional story: a legacy insurance group working through the long shadow of its older long‑term care policies while leaning on a solid mortgage insurance business and investing in a technology‑enabled senior‑care platform. Financially, it remains profitable with a more disciplined balance sheet, but with earnings and cash flow that can swing from year to year. Strategically, its deep data, experience, and regulatory know‑how in long‑term care are valuable assets, yet also sources of risk because of the long‑dated promises made to policyholders. The key opportunities lie in successfully modernizing long‑term care offerings, growing CareScout into a recognized platform for aging‑related services, and maintaining Enact’s strength in mortgage insurance. The main uncertainties are execution risk in this pivot, ongoing management of legacy liabilities, and exposure to housing and interest‑rate cycles. How well Genworth manages these trade‑offs will likely define its long‑term trajectory.
NEWS
November 5, 2025 · 4:15 PM UTC
Genworth Financial Announces Third Quarter 2025 Results
Read more
October 31, 2025 · 4:06 PM UTC
CareScout Completes Acquisition of Seniorly
Read more
October 22, 2025 · 8:50 AM UTC
Genworth Issues Statement on UK Court Approval of Santander Appeal Request
Read more
October 15, 2025 · 5:30 PM UTC
CareScout Announces Plan to Acquire Seniorly
Read more
October 9, 2025 · 4:15 PM UTC
Genworth Financial Schedules Earnings Conference Call for November 6
Read more

CEO
Thomas Joseph McInerney
Compensation Summary
(Year 2023)

CEO
Thomas Joseph McInerney
Compensation Summary
(Year 2023)
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Grade Summary
Institutional Ownership

BLACKROCK INC.
62.922M Shares
$546.162M

BLACKROCK, INC.
58.951M Shares
$511.692M

VANGUARD GROUP INC
45.724M Shares
$396.884M

DIMENSIONAL FUND ADVISORS LP
26.493M Shares
$229.963M

BLACKROCK FUND ADVISORS
26.364M Shares
$228.843M

DONALD SMITH & CO., INC.
24.976M Shares
$216.792M

STATE STREET CORP
17.909M Shares
$155.451M

RIVER ROAD ASSET MANAGEMENT, LLC
16.558M Shares
$143.726M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
14.854M Shares
$128.933M

GEODE CAPITAL MANAGEMENT, LLC
10.081M Shares
$87.503M

AMERICAN CENTURY COMPANIES INC
9.568M Shares
$83.046M

NUVEEN, LLC
9.558M Shares
$82.962M

FMR LLC
7.296M Shares
$63.331M

D. E. SHAW & CO., INC.
6.49M Shares
$56.332M

NORTHERN TRUST CORP
5.5M Shares
$47.741M

CITADEL ADVISORS LLC
5.298M Shares
$45.988M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
5.125M Shares
$44.483M

RENAISSANCE TECHNOLOGIES LLC
4.465M Shares
$38.755M

MORGAN STANLEY
4.11M Shares
$35.677M

INVESCO LTD.
3.835M Shares
$33.288M
Summary
Only Showing The Top 20



